Results 81 to 90 of about 1,095,153 (281)
Epidemiology and Treatment of Chronic Staphylococcal Infections in the Household
The epidemiological cycles of chronic staphylococcal infections in households are discussed and ther various methods of control that have been used are examined.
Hurst, V. +3 more
core +1 more source
Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b [PDF]
Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately faces innate immune reactions such as the activated complement system. Here, a novel innate immune evasion strategy of S. aureus is described.
Peter F. Zipfel +25 more
core +1 more source
A hierarchically selective immunotherapeutic nanoplatform, mGls@HEV‐MTP, selectively restores macrophage immunocompetence through GLS1‐mediated restoration of glutaminolysis‐fueled anaplerosis. Concurrently, it renders Staphylococcus aureus (S. aureus) more readily recognizable to the metabolically reprogrammed macrophages, thereby facilitating ...
Weinan Yang +17 more
wiley +1 more source
Studies on the ecology of Staphylocococcus Aureus and the epidemiology of Staphylococcal infections [PDF]
The differentiation of strains of Staphylococcus aureus isolated from infections and elsewhere in the environment has been difficult in the past because of the lack of suitable laboratory techniques for testing easily recognised and stable strain ...
Gould, James Cameron
core +3 more sources
Staphylococcus aureus is one of the major human bacterial pathogens causing a broad spectrum of serious infections. Myeloid-derived suppressor cells (MDSC) represent an innate immune cell subset capable of regulating host-pathogen interactions, yet their
Hartmut Stoll +19 more
doaj +1 more source
Treatment of staphylococcal infection [PDF]
Prescriptions must be part of a package that includes infection control W e have seen a spectacular rise in multiresistant Staphylococcus aureus (usually termed methicillin resistant Staphylococcus aureus— MRSA) in hospitals and care homes in the United Kingdom in the past five years.1 The emergence and spread of modern resistant bacteria are not ...
openaire +3 more sources
Updates on Staphylococcal Vaccines
Staphylococcus aureus, a prevalent human pathogen and a leading cause of hospital-acquired infections, is increasingly evolving antibiotic-resistant strains, increasing mortality and morbidity rates.
Gabriela-Loredana Popa +2 more
core +1 more source
An Injectable, Self‐Expanding Hemostatic Foam for Field‐Compatible Postpartum Hemorrhage Management
Postpartum hemorrhage is the leading cause of maternal death worldwide, yet many treatments are hard to use outside well‐equipped hospitals. This work introduces an easy‐to‐use device that rapidly delivers a degradable foam into the uterus. The foam stops bleeding through pressure and clotting support, offering a practical option for low‐resource ...
Charlotte Meyer +12 more
wiley +1 more source
Dual‐Targeted Biomimetic MoSe2 Nanozymes for Enhancing Peri‐Implant Soft Tissue Integration
A dual‐targeting biomimetic nanozyme, MoSe2@SPMM, selectively targets Staphylococcus aureus and oxidatively stressed macrophages. Near‐infrared activation couples contact‐enhanced photothermal bacterial eradication with reactive oxygen species scavenging to disrupt the pathogenic–immunological amplification loop.
Minghao Zhou +7 more
wiley +1 more source
Nebulized BN@NF nanozymes integrate boron nanosheets with Nd‐doped iron phosphide to form a sono‐magneto‐responsive Z‐scheme heterostructure. Under ultrasound and magnetic activation, BN@NF amplifies ROS generation, eradicates bacteria, disrupts biofilms, and reshapes pulmonary inflammation through NF‐κB suppression, mitophagy promotion, and M1‐to‐M2 ...
Xiaofeng Luo +6 more
wiley +1 more source

